W Szafrański

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

W Szafrański, Alberto Cukier, Ana Sofia Ramírez et al. · European Respiratory Journal · 2003 · 887 citations · Full text

A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo

Joan B. Soriano, Don D. Sin, Xuekui Zhang et al. · CHEST Journal · 2007 · 130 citations

Advanced Lung Disease, Clinical Epidemiology, Copd Patients Randomized +6

A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin (GC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC).

Nick Thatcher, Fred R. Hirsch, Aleksandra Szczęsna et al. · Journal of Clinical Oncology · 2014 · 41 citations

Immunology, Pathology, First-line Treatment +18

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer

Tudor–Eliade Ciuleanu, Mark A. Socinski, Coleman K. Obasaju et al. · Clinical Lung Cancer · 2017 · 23 citations

Medicine, Necitumumab Continuation Therapy, Cancer Management +4

[Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].

W Szafrański · PubMed · 2012 · 12 citations